30.07.2010 • News

Wacker Ends Q2 2010 with New Sales Record

Wacker Chemie ended Q2 2010 with a new sales record, primarily thanks to much higher sales volumes. Q2 2010 sales climbed 30% to €1,202.0 million (Q2 2009: €925.5 million). Growth was additionally driven by the stronger US dollar. In contrast, lower prices slowed the sales increase to some extent.

Wacker also posted clear earnings gains compared to both a year ago and Q1 2010. Earnings before interest, taxes, depreciation and amortization (Ebitda) in Q2 climbed to €308.6 million (Q2 2009: €170.1 million) up over 81% on the prior year, Ebitda rose at more than double the rate of sales.

Company

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.